xxviii Harm A.W.M. Tiddens reports that the “Sophia Research BV” of the Erasmus MC Sophia Children’s Hospital has, in the past 5 years, received unconditional research grants from Gilead Sciences Inc., Chiesi pharmaceuticals, Novartis, Vertex, Vectura and Roche, as well as research grants from the Innovative Medicines Initiative, the Cystic Fibrosis Foundation, the European Cystic Fibrosis Society and the Sophia foundation. H.A.W.M. Tiddens also reports honoraria and travel expenses for lectures and participation in expert panels from Novartis, Gilead, Roche, Pharmaxis, Insmed and Vertex a joint patent with Perth for PRAGMA-CF that has been submitted and that FLUIDDA has developed computational fluid dynamic modelling based on chest CTs obtained from Erasmus MC Sophia Children’s Hospital for which royalties are received by Sophia Research BV. Marcel van Straten reports non-financial support from Siemens Healthineers, outside the submitted work. Erika von Mutius reports personal fees for consultancy services from OM Pharma SA, Peptinnovate Ltd and Pharmaventures Ltd, speaker fees from Boehringer Ingelheim International GmbH, and speaker travel fees from Nestlé Deutschland AG, all outside the submitted work. In addition, E. von Mutius has a patent pending, application number LU101064, “Barn dust extract for the prevention and treatment of diseases” a patent with publication number EP2361632 “Specific environmental bacteria for the protection from and/ or the treatment of allergic, chronic inflammatory and/or autoimmune disorders”, with royalties paid to Protectimmun GmbH a patent with publication number EP1411977 “Composition containing bacterial antigens used for the prophylaxis and the treatment of allergic diseases”, licensed to Protectimmun GmbH a patent with publication number EP1637147 “Stable dust extract for allergy protection”, licensed to Protectimmun GmbH and a patent with publication number EP1964570 “Pharmaceutical compound to protect against allergies and inflammatory diseases”, licensed to Protectimmun GmbH. Sophie Yammine reports personal fees from Vertex, outside the submitted work.
Previous Page Next Page